美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读

2022-01-19 武汉大学人民医院胸外科 中国胸心血管外科临床杂志

静脉血栓栓塞症(venous thromboembolism,VTE)主要包括深静脉血栓形成和肺栓塞,VTE作为一种慢性疾病,造成了重大的全球疾病负担。美国胸科医师学会(American Colleg

中文标题:

美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读

发布日期:

2022-01-19

简要介绍:

静脉血栓栓塞症(venous thromboembolism,VTE)主要包括深静脉血栓形成和肺栓塞,VTE作为一种慢性疾病,造成了重大的全球疾病负担。美国胸科医师学会(American College of Chest Physicians,ACCP)第九版VTE抗栓治疗指南(AT9)于2012年发布,并于2016年第一次更新。2021年10月ACCP正式发布了AT9的第二次更新,本次更新就17个VTE相关的临床问题提出了共计29条推荐意见,本文就本次指南更新所提出的推荐意见进行解读。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=26ba01c00238e2d2, title=美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读, enTitle=, guiderFrom=中国胸心血管外科临床杂志, authorId=0, author=, summary=静脉血栓栓塞症(venous thromboembolism,VTE)主要包括深静脉血栓形成和肺栓塞,VTE作为一种慢性疾病,造成了重大的全球疾病负担。美国胸科医师学会(American Colleg, cover=https://img.medsci.cn/2022320/1647752875981_5579292.jpg, journalId=0, articlesId=null, associationId=2533, associationName=武汉大学人民医院胸外科, associationIntro=武汉大学人民医院胸外科, copyright=0, guiderPublishedTime=Wed Jan 19 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">静脉血栓栓塞症(venous thromboembolism,VTE)主要包括深静脉血栓形成和肺栓塞,VTE作为一种慢性疾病,造成了重大的全球疾病负担。美国胸科医师学会(American College of Chest Physicians,ACCP)第九版VTE抗栓治疗指南(AT9)于2012年发布,并于2016年第一次更新。2021年10月ACCP正式发布了AT9的第二次更新,本次更新就17个VTE相关的临床问题提出了共计29条推荐意见,本文就本次指南更新所提出的推荐意见进行解读。&nbsp;</span></p>, tagList=[TagDto(tagId=3301, tagName=抗栓治疗), TagDto(tagId=57456, tagName=静脉血栓栓塞症)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9808, appHits=288, showAppHits=0, pcHits=792, showPcHits=9514, likes=3, shares=60, comments=4, approvalStatus=1, publishedTime=Sun Mar 20 15:06:00 CST 2022, publishedTimeString=2022-01-19, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Sun Mar 20 13:08:56 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 14:55:00 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读.pdf)])
美国胸科医师学会第九版静脉血栓栓塞症抗栓治疗指南第二次更新解读.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2130013, encodeId=2abb2130013fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 04 10:17:10 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240972, encodeId=6f9512409e25e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fd4092069, createdName=13b84987m99暂无昵称, createdTime=Thu Aug 25 17:25:11 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204519, encodeId=e838120451977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Mon Mar 21 07:30:30 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2023-05-04 329523732 来自广东省

    不错

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2130013, encodeId=2abb2130013fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 04 10:17:10 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240972, encodeId=6f9512409e25e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fd4092069, createdName=13b84987m99暂无昵称, createdTime=Thu Aug 25 17:25:11 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204519, encodeId=e838120451977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Mon Mar 21 07:30:30 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-08-25 13b84987m99暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2130013, encodeId=2abb2130013fc, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Thu May 04 10:17:10 CST 2023, time=2023-05-04, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1240972, encodeId=6f9512409e25e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=61fd4092069, createdName=13b84987m99暂无昵称, createdTime=Thu Aug 25 17:25:11 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204519, encodeId=e838120451977, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=c40a6387446, createdName=ms3000000376140643, createdTime=Mon Mar 21 07:30:30 CST 2022, time=2022-03-21, status=1, ipAttribution=)]
    2022-03-21 ms3000000376140643

    学习学习

    0